A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...

Monitoring of clinical events in patients on first line antiretroviral treatment (ART) in poor countries is almost as effective in terms of survival as using CD4 count or viral load measures at ...

This table pertains to laboratory tests done to select an ARV regimen and monitor for treatment responses or ART toxicities. Please refer to the HIV Primary Care guidelines for guidance on other ...

Background. It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)–monoinfected patients with suppressed viral loads and CD4 cell counts >300 cell/μL could ...

ART recommended for all with HIV, regardless of CD4 count New recommendations state that all patients with HIV be treated with antiretroviral therapy (ART) regardless of CD4 cell count. HealthDay News ...

Treatment interruptions in patients with prolonged immunologic and virologic responses to highly active antiretroviral therapy (HAART) have been advocated in many circles, especially if the CD4+ count ...

This supplement on evaluating CD4 diagnostics for HIV is the fourth in a series of user-friendly operational guides explaining how to conduct evaluations of diagnostic tests for infectious diseases ...

July 30, 2010 (Vienna, Austria) — Although initiation of highly active antiretroviral therapy (HAART) against HIV is associated with a lower risk for progression to AIDS, and a lower risk for ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical assessment.

HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative ...

National Institutes of Health researchers shared new details about idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...